D-0452-2017 Class II Terminated
FDA drug recall D-0452-2017 was initiated by Dr. Reddy's Laboratories, Inc. on Dec 28, 2016 and is designated Class II. Reason for recall: Failed Dissolution Specifications; 18 month stability time point The recall status is terminated (terminated Oct 19, 2017). Affected quantity: a) 38,832 and b) 5,064 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 8, 2017
- Initiation Date
- Dec 28, 2016
- Termination Date
- Oct 19, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 38,832 and b) 5,064 bottles
Product description
Flucanozole Tablets, USP, 200 mg, a) 30 count (NDC 55111-146-30) and b) 100 count (NDC 55111-146-01) bottles, Rx Only, Mfd. by: Dr. Reddy's Laboratories, Bachupally 500 090 India
Reason for recall
Failed Dissolution Specifications; 18 month stability time point
Distribution pattern
Nationwide
Code information
a) 30 count C500228, exp 12/2016, C500848 and C500850, exp 01/2017 C503651 and C503653, exp 04/2017, b) 100 count C500226, exp 12/2016, C500848, C500850, exp 01/2017, C503649 and C503653, exp 04/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0452-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026